Singapore, Central Region, Singapore | Fund Name | Location |
| 080808 Capital | New York, New York, United States |
| Binyou Network Technology | China, Shanghai |
| Business Valley | Al Qahirah, Cairo, Egypt |
| ConnectCapital | Bombay, India, Maharashtra |
| Droi | China, Shanghai, Xuhui |
| Eos Venture Partners | England, London, United Kingdom |
| Huazansheng Touzi | China, Jiaxing, Zhejiang |
| InnoStar Venture | - |
| National Education Association | District of Columbia, United States, Washington |
| North East Technology Fund | England, London, United Kingdom |
| ORC International | New Jersey, Princeton, United States |
| Seek Capital Management | - |
| TDH Capital | Pennsylvania, Radnor, United States |
| TNB Ventures | Central, Central Region, Singapore |
| Tsinghua Tongfang | Beijing, Beijing, China |
| Vento Security Holdings | Massachusetts, Nantucket, United States |
| Ying Fund | California, Los Angeles, United States |
| Zhen Shun Investment Management | Beijing, Beijing, China |
| ZMV Associates | New York, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
ASLAN Pharmaceuticals | $34M | 07 Dec 2015 | Singapore, Central Region, Singapore |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
ASLAN Pharmaceuticals | $34M | 07 Dec 2015 | Singapore, Central Region, Singapore |
